Regeneron Pharmaceuticals ROA - Return on Assets 2010-2024 | REGN

Regeneron Pharmaceuticals return on assets for the quarter ending September 30, 2024 was 13.21.

  • Regeneron Pharmaceuticals average return on assets for 2023 was 13.73, a 39.49% decline from 2022.
  • Regeneron Pharmaceuticals average return on assets for 2022 was 22.69, a 30.29% decline from 2021.
  • Regeneron Pharmaceuticals average return on assets for 2021 was 32.55, a 65.06% decline from 2020.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.

Regeneron Pharmaceuticals ROA - Return on Assets 2010-2024 | REGN

  • Regeneron Pharmaceuticals average return on assets for 2023 was 13.73, a 39.49% decline from 2022.
  • Regeneron Pharmaceuticals average return on assets for 2022 was 22.69, a 30.29% decline from 2021.
  • Regeneron Pharmaceuticals average return on assets for 2021 was 32.55, a 65.06% decline from 2020.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.